Increased monocyte tissue factor expression in coronary disease

E W Leatham1, P M Bath, J A Tooze

  • 1Department of Cardiological Sciences, St George's Hospital Medical School, London.

British Heart Journal
|January 1, 1995
PubMed

Insights

Monocyte tissue factor expression is elevated in patients with acute coronary syndromes and chronic stable angina, contributing to hypercoagulability. This finding highlights tissue factor

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Immunology

Background:

  • Unstable angina and myocardial infarction are linked to increased mononuclear cell procoagulant activity.
  • Monocyte procoagulant activity is primarily mediated by tissue factor (TF) expression.
  • TF initiates the coagulation cascade, suggesting a potential role in ischemic heart disease syndromes.

Purpose of the Study:

  • To determine if monocyte expression of tissue factor (TF) is elevated in patients with acute coronary syndromes (ACS) and chronic stable angina (CSA).
  • To investigate the association between TF expression on monocytes and ischemic heart disease.

Main Methods:

  • A cross-sectional study design was employed.
  • Monocyte TF expression was quantified using flow cytometry with a polyclonal rabbit anti-human TF antibody.
  • Participants included patients with acute myocardial infarction (AMI), unstable angina (UA), CSA, and healthy controls.

Main Results:

  • Significantly higher proportions of monocytes expressing TF were observed in patients with CSA (38%), UA (64%), and AMI (53%) compared to controls (0%).
  • Monocyte TF expression levels were statistically significant across the patient groups (2P = 0.006).
  • Lipopolysaccharide stimulation resulted in similar monocyte TF expression across all subjects, indicating disease-specific upregulation.

Conclusions:

  • Elevated tissue factor expression on circulating monocytes may contribute to the hypercoagulable state associated with AMI, UA, and CSA.
  • Monocyte TF represents a potential therapeutic target for managing thrombotic complications in ischemic heart disease.
Abstract

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...